GREENSBORO, N.C.--(BUSINESS WIRE)--Merz North America (U.S. affiliate of the global Merz Pharma Group), today announced that it will award up to $1,000,000 in grants to the Dystonia Medical Research Foundation’s (DMRF) Clinical Fellowship Training Program over the course of the next three years. Merz’s contribution will fund one-year fellowship grants to advance physician training and education in the diagnosis and treatment of dystonia, a neurological movement disorder that causes involuntary muscle spasms.
“Here at Merz, we believe that one of the most important ways we can support dystonia patients is to fund physician training and education. By providing funding for the DMRF Clinical Fellowship Training Program, we hope to raise awareness of dystonia among the next generation of movement disorder physicians, ensuring that they are better prepared to diagnose and treat this rare but serious disease,“ said Bill Humphries, President and Chief Executive Officer for Merz North America, Inc.
Help employers find you! Check out all the jobs and post your resume.
“Here at Merz, we believe that one of the most important ways we can support dystonia patients is to fund physician training and education. By providing funding for the DMRF Clinical Fellowship Training Program, we hope to raise awareness of dystonia among the next generation of movement disorder physicians, ensuring that they are better prepared to diagnose and treat this rare but serious disease,“ said Bill Humphries, President and Chief Executive Officer for Merz North America, Inc.
Help employers find you! Check out all the jobs and post your resume.
